Global Financial Private Client, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Global Financial Private Client, LLC
- $257 Billion
- Q3 2024
A detailed history of Global Financial Private Client, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 65 shares of REGN stock, worth $52,281. This represents 0.03% of its overall portfolio holdings.
Number of Shares
65
Previous 44
47.73%
Holding current value
$52,281
Previous $46.2 Million
47.76%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,505Shares Held
85.3MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.79 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$6.02 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.89 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.46 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $86.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...